Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

AK, GÜNTÜLÜ; Tada, Yuji; Shimada, Hideaki; METİNTAŞ, SELMA; Ito, Masaaki; Hiroshima, Kenzo; Tagawa, Masatoshi; METİNTAŞ, MUZAFFER

doi:10.1186/s12885-017-3209-5

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

Atıf İçin Kopyala

AK G. , Tada Y., Shimada H., METİNTAŞ S. , Ito M., Hiroshima K., ...Daha Fazla

BMC CANCER, cilt.17, 2017 (SCI İndekslerine Giren Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17
Basım Tarihi: 2017
Doi Numarası: 10.1186/s12885-017-3209-5
Dergi Adı: BMC CANCER

Özet

Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.